Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 25% ± 9% | |
lung | 11 studies | 24% ± 9% | |
intestine | 9 studies | 25% ± 11% | |
kidney | 8 studies | 29% ± 4% | |
liver | 7 studies | 31% ± 22% | |
brain | 6 studies | 25% ± 6% | |
lymph node | 5 studies | 22% ± 9% | |
bone marrow | 4 studies | 22% ± 4% | |
placenta | 3 studies | 47% ± 25% | |
prostate | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 14991.00 | 89 / 89 | 99% | 216.18 | 893 / 901 |
intestine | 100% | 8845.45 | 964 / 966 | 99% | 285.45 | 523 / 527 |
liver | 100% | 18724.89 | 226 / 226 | 99% | 265.82 | 402 / 406 |
prostate | 99% | 8183.68 | 243 / 245 | 100% | 280.72 | 501 / 502 |
esophagus | 99% | 8618.63 | 1434 / 1445 | 99% | 163.18 | 182 / 183 |
stomach | 100% | 13990.90 | 358 / 359 | 99% | 246.23 | 282 / 286 |
bladder | 100% | 4648.71 | 21 / 21 | 98% | 230.00 | 493 / 504 |
pancreas | 100% | 8358.19 | 328 / 328 | 97% | 120.56 | 173 / 178 |
brain | 95% | 5391.51 | 2516 / 2642 | 100% | 201.40 | 705 / 705 |
lung | 95% | 3555.80 | 551 / 578 | 99% | 200.64 | 1144 / 1155 |
skin | 94% | 5484.91 | 1695 / 1809 | 92% | 111.73 | 432 / 472 |
breast | 84% | 3656.61 | 384 / 459 | 99% | 300.41 | 1111 / 1118 |
uterus | 75% | 2179.58 | 128 / 170 | 100% | 297.70 | 459 / 459 |
thymus | 59% | 1443.52 | 387 / 653 | 89% | 102.07 | 539 / 605 |
ovary | 34% | 763.41 | 62 / 180 | 99% | 206.88 | 426 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 265.51 | 29 / 29 |
muscle | 100% | 42277.54 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 238.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 139.35 | 1 / 1 |
spleen | 99% | 4223.88 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 22694.51 | 848 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 2815.32 | 1134 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 5263.99 | 740 / 929 | 0% | 0 | 0 / 0 |
adipose | 70% | 1957.51 | 845 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 55.86 | 53 / 80 |
adrenal gland | 6% | 127.45 | 16 / 258 | 31% | 22.40 | 72 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006739 | Biological process | NADP metabolic process |
GO_0006103 | Biological process | 2-oxoglutarate metabolic process |
GO_0006097 | Biological process | glyoxylate cycle |
GO_0006102 | Biological process | isocitrate metabolic process |
GO_0006099 | Biological process | tricarboxylic acid cycle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0051287 | Molecular function | NAD binding |
GO_0004450 | Molecular function | isocitrate dehydrogenase (NADP+) activity |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | IDH2 |
Protein name | isocitrate dehydrogenase (NADP(+)) (EC 1.1.1.42) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) Isocitrate dehydrogenase Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) Isocitrate dehydrogenase (NADP(+)) 2 |
Synonyms | |
Description | FUNCTION: Plays a role in intermediary metabolism and energy production . It may tightly associate or interact with the pyruvate dehydrogenase complex . . |
Accessions | ENST00000560061.1 ENST00000540499.2 [P48735-2] P48735 ENST00000559482.5 A0A1P8A7C0 H0YLL5 ENST00000330062.8 [P48735-1] H0YL11 |